NCT05105009View on ClinicalTrials.gov

Furosemide and Creatinine Tubular Stress Test in Order to Measure Proximal Tubule Residual Function

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 3, 2020

Primary Completion Date

October 21, 2023

Study Completion Date

August 27, 2024

Conditions
Chronic Kidney Failure
Interventions
DRUG

Furosemide Injection

"* Furosemide Stress Test ( 1mg/kg in non diuretic users and 1.5 mg/kg in diuretic users).~* Oral creatinine load using 5 grams of creatinine"

DRUG

Creatinine Powder

5g of creatinine (Sigma) in 250 ml of water was taken orally

DRUG

Iohexol

5 ml iohexol (Omnipaque) intravenously

Trial Locations (1)

14080

Instituto Nacional de Cardiologia Ignacio Chávez, Mexico City

All Listed Sponsors
lead

Instituto Nacional de Cardiologia Ignacio Chavez

OTHER

NCT05105009 - Furosemide and Creatinine Tubular Stress Test in Order to Measure Proximal Tubule Residual Function | Biotech Hunter | Biotech Hunter